Patents by Inventor María de las Ermitas Alcalde-Pais

María de las Ermitas Alcalde-Pais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments
    Patent number: 9617281
    Abstract: The present invention relates to new imidazo[2,1-b]thiazole derivatives having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.
    Type: Grant
    Filed: July 4, 2013
    Date of Patent: April 11, 2017
    Assignee: LABORATORIES DEL DR. ESTEVE S.A.
    Inventors: María de las Ermitas Alcalde-Pais, José Luís Diaz Fernández, María de les Neus Mesquida-Estevez, Laura Paloma-Romeu
  • Substituted indenes as medicaments
    Patent number: 9493434
    Abstract: The present invention relates to new indene derivatives of formula (I) having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: November 15, 2016
    Assignee: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Maria de las Ermitas Alcalde-Pais, Carmen Almansa-Rosales, José´Luis Diaz Fernández, María de les Neus Mesquida-Estevez, Laura Paloma-Romeu
  • IMIDAZO[2,1-b]THIAZOLE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
    Publication number: 20150166574
    Abstract: The present invention relates to new imidazo[2,1-b]thiazole derivatives having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.
    Type: Application
    Filed: July 4, 2013
    Publication date: June 18, 2015
    Inventors: María de las Ermitas Alcalde-Pais, José-Luís Díaz-Fernández, María de les Neus Mesquida-Estevez, Laura Paloma-Romeu
  • INDENE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
    Publication number: 20150158831
    Abstract: The present invention relates to new indene derivatives having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.
    Type: Application
    Filed: July 3, 2013
    Publication date: June 11, 2015
    Inventors: María de las Ermitas Alcalde-Pais, Carmen Almansa-Rosales, José Luís Diaz Fernández, María de les Neus Mesquida-Estevez, Laura Paloma-Romeu
  • Indene derivatives, their preparation and use as medicaments
    Patent number: 8217041
    Abstract: The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: July 10, 2012
    Assignee: Laboratories del Sr. Esteve, S.A.
    Inventors: Maria de las Ermitas Alcalde-Pais, Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal, Maria de les Neus Mesquida-Estevez, Sara Lopez-Perez
  • Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
    Patent number: 8138210
    Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: March 20, 2012
    Assignee: Laboratorios Del Dr. Esteve, S.A.
    Inventors: Maria De Las Ermitas Alcalde-Pais, Maria De Les Neus Mesquida-Estevez, Sara Lopez-Perez, Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal
  • SUBSTITUTED INDANYL SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS
    Publication number: 20100069378
    Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Application
    Filed: July 25, 2007
    Publication date: March 18, 2010
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal, Maria de las Ermitas Alcalde-Pais, Maria de les Neus Mesquida-Estevez, Sara Lopez-Perez
  • INDENE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
    Publication number: 20090163547
    Abstract: The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Application
    Filed: November 7, 2006
    Publication date: June 25, 2009
    Inventors: Maria De Las Ermitas Alcalde-Pais, Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal, Maria De Les Neus Mesquida-Estevez, Sara Lopez-Perez
  • Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
    Publication number: 20080027073
    Abstract: The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
    Type: Application
    Filed: August 18, 2006
    Publication date: January 31, 2008
    Applicant: Laboratorios Del Dr. Esteve, S.A.
    Inventors: Maria De Las Ermitas Alcalde-Pais, Maria De Les Neus Mesquida-Estevez, Sara Lopez-Perez, Jordi Frigola-Constansa, Joerg Holenz, Ramon Merce-Vidal